Phenotypes of Obesity: How It Impacts Management

Overview

Journal Curr Gastroenterol Rep

Specialty Gastroenterology

Date 2017 Sep 27

PMID 28948512

Citations 8

Authors

Meera Shah

Ryan T Hurt

Manpreet S Mundi

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: The worldwide prevalence of obesity is increasing. Obesity is strongly associated with many chronic health conditions that have been shown to improve with weight loss. However, counseling patients on weight loss can be challenging. Identifying specific aspects of weight management may personalize the conversation about weight loss and better address the individual patient's health goals and perceived barriers to change.

Recent Findings: Physical and behavioral phenotypes are being identified to better tailor treatment recommendations, given lack of efficacy of currently available interventions. The current review provides a summary of the evidence behind the management of several recognized clinical phenotypes, to include body fat distribution (e.g., central obesity), muscle mass (e.g., sarcopenic obesity of the elderly), and problematic eating behaviors (e.g., cravings). Identifying specific aspects of weight management may personalize the conversation about weight loss and better address the individual patient's health goals and perceived barriers to change.

Citing Articles

Exploring the Effect of the Dynamics of Behavioral Phenotypes on Health Outcomes in an mHealth Intervention for Childhood Obesity: Longitudinal Observational Study.

Woo S, Jung S, Lim H, Kim Y, Park K J Med Internet Res. 2023; 25:e45407.

PMID: 37590040 PMC: 10472181. DOI: 10.2196/45407.

Comparison between handheld ultrasound and regional and whole-body dual energy x-ray absorptiometry (DXA) for body fat assessment.

Gomez-Perez S, Zhang Y, Mourtzakis M, Tussing-Humphreys L, Ridlon J, Gaskins H Clin Nutr ESPEN. 2021; 46:386-393.

PMID: 34857225 PMC: 8646977. DOI: 10.1016/j.clnesp.2021.08.038.

When Pandemics Collide: the Interplay of Obesity and COVID-19.

Mundi M, Patel J, Mohamed Elfadil O, Patel J, Patel I, Nanda S Curr Gastroenterol Rep. 2021; 23(12):26.

PMID: 34735631 PMC: 8566966. DOI: 10.1007/s11894-021-00822-5.

Relationship between trait suggestibility and eating-related behaviors in overweight and obesity.

Ray M, Zachmann A, Caudill C, Boggiano M Eat Behav. 2020; 37:101380.

PMID: 32193130 PMC: 7246141. DOI: 10.1016/j.eatbeh.2020.101380.

Sweet cognition: The differential effects of glucose consumption on attentional food bias in individuals of lean and obese status.

Mason A, Jhaveri K, Schleicher S, Almeida C, Hartman A, Wackerly A Physiol Behav. 2019; 206:264-273.

PMID: 31002858 PMC: 6563839. DOI: 10.1016/j.physbeh.2019.04.014.

References

Caan B, Armstrong M, Selby J, Sadler M, Folsom A, Jacobs D . Changes in measurements of body fat distribution accompanying weight change. Int J Obes Relat Metab Disord. 1994; 18(6):397-404. View

Boyko E, Leonetti D, Bergstrom R, Newell-Morris L, Fujimoto W . Visceral adiposity, fasting plasma insulin, and blood pressure in Japanese-Americans. Diabetes Care. 1995; 18(2):174-81. DOI: 10.2337/diacare.18.2.174. View

Wei M, Gaskill S, Haffner S, Stern M . Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans--a 7-year prospective study. Obes Res. 1997; 5(1):16-23. DOI: 10.1002/j.1550-8528.1997.tb00278.x. View

Reas D, Grilo C . Review and meta-analysis of pharmacotherapy for binge-eating disorder. Obesity (Silver Spring). 2009; 16(9):2024-38. PMC: 3650491. DOI: 10.1038/oby.2008.333. View

Bouchonville M, Villareal D . Sarcopenic obesity: how do we treat it?. Curr Opin Endocrinol Diabetes Obes. 2013; 20(5):412-9. PMC: 4046899. DOI: 10.1097/01.med.0000433071.11466.7f. View

Villareal D, Apovian C, Kushner R, Klein S . Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am J Clin Nutr. 2005; 82(5):923-34. DOI: 10.1093/ajcn/82.5.923. View

Bhasin S, Woodhouse L, Casaburi R, Singh A, Mac R, Lee M . Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab. 2004; 90(2):678-88. DOI: 10.1210/jc.2004-1184. View

Acosta A, Abu Dayyeh B, Port J, Camilleri M . Recent advances in clinical practice challenges and opportunities in the management of obesity. Gut. 2014; 63(4):687-95. PMC: 4170188. DOI: 10.1136/gutjnl-2013-306235. View

Calle E, Rodriguez C, Walker-Thurmond K, Thun M . Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003; 348(17):1625-38. DOI: 10.1056/NEJMoa021423. View

10.

. 1983 metropolitan height and weight tables. Stat Bull Metrop Life Found. 1983; 64(1):3-9. View

11.

Greenway F, Fujioka K, Plodkowski R, Mudaliar S, Guttadauria M, Erickson J . Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010; 376(9741):595-605. DOI: 10.1016/S0140-6736(10)60888-4. View

12.

Flegal K, Kit B, Orpana H, Graubard B . Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013; 309(1):71-82. PMC: 4855514. DOI: 10.1001/jama.2012.113905. View

13.

Garcia-Garcia I, Horstmann A, Jurado M, Garolera M, Chaudhry S, Margulies D . Reward processing in obesity, substance addiction and non-substance addiction. Obes Rev. 2014; 15(11):853-69. DOI: 10.1111/obr.12221. View

14.

Egger G, Bolton A, ONeill M, Freeman D . Effectiveness of an abdominal obesity reduction programme in men: the GutBuster "waist loss' programme. Int J Obes Relat Metab Disord. 1996; 20(3):227-31. View

15.

Smith S, Fujioka K, Gupta A, Billes S, Burns C, Kim D . Combination therapy with naltrexone and bupropion for obesity reduces total and visceral adiposity. Diabetes Obes Metab. 2013; 15(9):863-6. DOI: 10.1111/dom.12095. View

16.

Thompson C, Ryu J, Craven T, KAHL F, Crouse 3rd J . Central adipose distribution is related to coronary atherosclerosis. Arterioscler Thromb. 1991; 11(2):327-33. DOI: 10.1161/01.atv.11.2.327. View

17.

Yarasheski K, Bhasin S, Sinha-Hikim I, Gonzalez-Cadavid N . Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting. J Nutr Health Aging. 2002; 6(5):343-8. View

18.

Giannoulis M, Martin F, Nair K, Umpleby A, Sonksen P . Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?. Endocr Rev. 2012; 33(3):314-77. PMC: 5393154. DOI: 10.1210/er.2012-1002. View

19.

Der-Torossian H, Wysong A, Shadfar S, Willis M, McDunn J, Couch M . Metabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexia. J Cachexia Sarcopenia Muscle. 2013; 4(2):145-55. PMC: 3684703. DOI: 10.1007/s13539-012-0101-7. View

20.

Smith S, Stenlof K, Greenway F, McHutchison J, Schwartz S, Dev V . Orlistat 60 mg reduces visceral adipose tissue: a 24-week randomized, placebo-controlled, multicenter trial. Obesity (Silver Spring). 2011; 19(9):1796-803. DOI: 10.1038/oby.2011.143. View